Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers...
Hovione has appointed Jean-Luc Herbeaux as Hovione’s Chief Executive Officer (CEO), effective April 1, 2022. He will succeed Guy Villax, who has been the company’s CEO...
So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...
11.04.2019
- The chemical industry is one of the most international sectors with activity dominated by cross border transactions. Chinese and other Asian firms have been particularly busy...
31.08.2018
- Outsourcing is about the efficiencies of globalization, expense, people, and the challenge of drug discovery. Big Pharma has consolidated and faltered over the past 15 to 20 years...
08.03.2018
- Hovione plans to withdraw from generic contrast media manufacturing to focus on other business segments including contract development and manufacturing of innovative therapies and...
29.11.2012
- Hovione and Solvias today announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's...
